Every piece of research we've covered — across genetics, neuroscience, ecology, immunology, and more.
A treatment strategy borrowing from both cancer immunotherapy and mRNA vaccine technology is being tested against cardiac fibrosis, the scarring that drives heart failure and has no good current treatment.
Multiple 2025 studies show that environmental stresses experienced by a father — diet, toxins, even psychological stress — leave epigenetic marks on sperm that affect their offspring's development.
A wave of stem-cell-based embryo models now reproduces early human and mouse development with growing fidelity, offering a way to study the period that has long been least accessible to research.
Cornell researchers found a way to use proteins cells already make as built-in sensors, reporting on what's happening inside without the usual invasive labels or genetic tweaks.
A team in Brussels showed that monocytes recruited into the brain can be coaxed into adopting the identity of microglia — opening a route to repopulating the brain's immune system after injury or disease.
Google's AI co-scientist was asked to explain how certain bacterial parasites jump between species. Without prior training on the topic, it arrived at the same mechanism researchers had spent years uncovering — in 48 hours.
A team at Rockefeller University built a setup that keeps a working sliver of the inner ear alive on a benchtop, letting researchers watch hair cells amplify sound in real time — and opening a new window onto hearing loss.
A University of Pittsburgh team found that T cells collected after a meal are metabolically primed to mount stronger immune responses than fasted T cells — an effect that persists for days and could change how researchers time vaccinations and engineer CAR-T therapies.
McGill researchers used a fast click chemistry reaction to crosslink red blood cell proteins, producing engineered clots that gel in five seconds and resist tearing thirteen times better than natural ones — a promising direction for severe bleeding control.
UC Irvine researchers restored vision in aged mice by injecting a single very-long-chain fatty acid into the eye, bypassing a declining aging-linked enzyme and reversing retinal markers of old age.
A previously unknown virus living inside the common gut bacterium Bacteroides fragilis shows up roughly twice as often in people with colorectal cancer — a clue that could reshape screening and reopen a long-standing paradox in cancer microbiology.
A 289-million-year-old reptile preserved with skin, cartilage, and even protein remnants has given paleontologists their earliest direct look at rib-powered breathing — the system that let early amniotes thrive on land.
An international team of synthetic biologists published a landmark framework for building a living cell from molecular components, mapping both the scientific obstacles and a realistic path through them.
Researchers engineered a common gut bacterium to break down oxalate — the main compound in kidney stones — directly in the intestine, with the bacteria colonizing stably without disrupting the rest of the microbiome.
Rockefeller scientists found that serine — a simple amino acid — acts as a nutrient sensor in hair-follicle stem cells, signaling them to switch from hair growth to wound repair when tissue is damaged.
Researchers trained an AI on T cell receptor sequences from a standard blood draw and found it could accurately distinguish over a dozen autoimmune diseases — potentially replacing years-long diagnostic delays.
A gene therapy called AMT-130 has shown remarkable results in clinical trials, slowing the progression of Huntington's disease by around 75% — the first therapy to meaningfully target the disease's root cause.
Marine biologists have used CRISPR gene editing to create coral species that can better survive ocean warming and acidification.
Researchers have developed an advanced AI model capable of predicting protein structures that have resisted conventional computational and experimental techniques.
A new broad-spectrum antivenom developed using synthetic antibodies can counter venom from multiple snake species — potentially transforming treatment for snakebite victims worldwide.
A groundbreaking AI model can predict how viruses will mutate, potentially giving scientists a head start in developing vaccines and treatments before outbreaks spiral.
Researchers have developed a synthetic human embryo model using stem cells — without sperm, eggs, or a womb — offering a powerful new window into early human development and ethics.
A new AI model simulates protein folding in real time, revealing every step of the process—offering critical insight into misfolding diseases like Alzheimer’s.
New research suggests pea plants can learn by association, responding to air movement as a cue for light.
Scientists use virus-like particles to deliver CRISPR into gut bacteria—editing genes directly inside living mice.
Gene therapy targeting the OTOF gene restores hearing in mice born deaf—raising hopes for treating human genetic deafness.
Scientists build tiny regenerative "Xenobots" from frog cells that can move, heal, and perform basic tasks.
Scientists discover that certain algae species are helping bleached corals bounce back faster in warming oceans.
A new implantable biosensor can detect infections and inflammatory responses before symptoms develop—paving the way for predictive medicine.
New research reveals that so-called “junk DNA” helps control gene expression, reshaping our understanding of the genome.
Researchers use AI-driven stimulation to help early-stage dementia patients recover lost memories.
CRISPR-edited mosquitoes unable to carry malaria parasites show promise in reducing transmission.
Synthetic enzymes engineered by AI catalyze chemical reactions up to 4x faster than their natural counterparts.
Researchers unveil an mRNA-based universal flu vaccine showing 88% effectiveness across multiple flu strains.
A new non-invasive blood test can detect early Alzheimer’s years before symptoms appear, potentially transforming screening and treatment.
Scientists have used CRISPR to stimulate regeneration of heart cells in mice, offering hope for reversing damage from heart attacks.
A breakthrough in neurotechnology enables AI models to convert brain signals into speech, opening doors for nonverbal communication.
Scientists have used CRISPR to reverse a previously untreatable genetic disorder in a live patient — marking a major step forward in human gene therapy.
Weekly research updates, breakthrough summaries, and new articles — straight to your inbox. Free, always.
